Secondary leukemias in refractory germ cell tumor patients undergoing autologous stem-cell transplantation using high-dose etoposide

Journal of Clinical Oncology

Volumn 22, Issue 11, 2004, Pages 2155-2158

  Houck, William ^a   Abonour, Rafat ^a   Vance, Gail ^a   Einhorn, Lawrence H ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; ETOPOSIDE; ANTINEOPLASTIC AGENT;

ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RELAPSE; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOPENIA; DRUG MEGADOSE; GERM CELL TUMOR; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; MONOSOMY; MYELOID LEUKEMIA; PRIORITY JOURNAL; SALVAGE THERAPY; TESTIS CANCER; ADOLESCENT; ADULT; AUTOTRANSPLANTATION; CHEMICALLY INDUCED DISORDER; INCIDENCE; LEUKEMIA; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROSTATE TUMOR; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION; UNITED STATES;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARBOPLATIN; COMBINED MODALITY THERAPY; ETOPOSIDE; GERMINOMA; HUMANS; INCIDENCE; INDIANA; LEUKEMIA; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS;

EID: 2942670655     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.11.054     Document Type: Article

References (20)

1. Einhorn L: Testicular cancer: An oncological success story. Clin Cancer Res 3:2630-2632, 1997
2. Murphy B, Breeden E, Donohue J, et al: Surgical salvage of chemorefractory germ cell tumors. J Clin Oncol 11:1294-1299, 1993
3. Loehrer P, Gonin R, Nichols C, et al: Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor. J Clin Oncol 16:2500-2504, 1998
4. Motzer R, Mazumdar M, Sheinfeld J, et al: Sequential dose-intensive paclitaxel, ifosfamide, carboplatin, and etoposide salvage therapy for germ cell tumor patients. J Clin Oncol 18:1173-1180, 2000
5. Bhatia S, Abonour R, Porcu P, et al: High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer. J Clin Oncol 18:3346-3351, 2000
6. Felix C: Leukemias related to treatment with DNA topoisomerase II inhibitors. Med Pediatr Oncol 36:525-535, 2001
7. Pedersen-Bjergaard J, Daugaard G, Hansen S, et al: Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours. Lancet 338:359-363, 1991
8. Nichols C, Breeden E, Loehrer P, et al: Secondary leukemia associated with a conventional dose of etoposide: Review of serial germ cell tumor protocols. J Natl Cancer Inst 85:36-40, 1993
9. Bajorin D, Motzer R, Rodriguez E, et al: Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy. J Natl Cancer Inst 85:60-62, 1993
10. Kollmannsberger C, Hartmann J, Kanz L, et al: Risk of secondary leukemia and myelodysplastic syndrome following standard dose chemotherapy or high dose chemotherapy with stem cell support in patients with potentially curable malignancies. J Cancer Res Clin Oncol 124:207-214, 1998
11. Broun E, Nichols C, Turns M, et al: Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support. Cancer 73:1716-1720, 1994
12. Vaena D, Abonour R, Einhorn L: Long-term survival after high-dose salvage chemotherapy for germ cell malignancies with adverse prognostic variables. Proc Am Soc Clin Oncol 22:383, 2003 (abstr 1538)
13. Broun E, Nichols C, Kneebone P, et al: Long-term outcome of patients with relapsed and refractory germ cell tumors treated with high-dose chemotherapy and autologous bone marrow rescue. Ann Intern Med 117:124-128, 1992
14. Le Deley, Leblanc T, Shamsaldin A, et al: Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: A case-control study by the Societe Francaise d'Oncologie Pediatrique. J Clin Oncol 21:1074-1081, 2003
15. Pui C, Ribeiro R, Hancock M. et al: Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 325:1682-1687, 1991
16. Smith M, Rubinstein L, Anderson J, et al: Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins. J Clin Oncol 17:569-577, 1999
17. Andersen M, Ribeiro R, Hancock M, et al: Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: Report on two new cases and review of the literature since 1992. Br J Haematol 114:539-543, 2001
18. Pedersen-Bjergaard J: Acute lymphoid leukemia with t(4;11) (q21;q23) following chemotherapy with cytostatic agents targeting at DNA-topoisomerase II. Leuk Res 16:733-735, 1992
19. Travis L, Andersson M, Gospodarowicz M, et al: Treatment associated leukemia following testicular cancer. J Natl Cancer Inst 92:1165-1171, 2000
20. Bokemeyer C, Schmoll H, Kuczyk M, et al: Risk of secondary leukemia following high cumulative doses of etoposide during chemotherapy for testicular cancer. J Natl Cancer Inst 87:58-60, 1995